Health Industry Hub

Blue screens have taken over computers and laptops in offices across the country as major tech outage forces many businesses into chaos… https://lnkd.in/gEa3kvhX

Noxopharm CEO Dr Gisela Mautner scooped the inaugural Brooker Prize for Impact in Life Sciences last night. It’s great recognition for her and the company, and congratulations to all the finalists on a good night for the industry. #lifesciences #biotech #ceoaward #impactaward #leadershipaward

Australia has world-leading #clinicaltrials infrastructure with streamlined regulatory approvals, R&D tax incentives, diverse patient populations, and world-class clinical investigators. But Australians can't take our competitive advantage for granted. The Asia Pacific region is driving significant growth in #biopharma #innovation. In 2013, Asia contributed around 20% to global biopharma innovation growing to nearly 40% in 2023. This rapid growth is set to continue with countries such as Singapore, South Korea, Thailand and Malaysia developing integrated and coordinated policies across different areas of government to attract more R&D investment and create further competitiveness. A strategic, coordinated, and whole-of-government approach is required to ensure we remain competitive and taxpayers and patients benefit from R&D investment. Thank you Rozalina Sarkezians and Health Industry Hub for the opportunity to have this discussion.

Very grateful for the opportunity to talk about diabetes, research, the Parliamentary Inquiry into Diabetes and how we can improve the lives of all people living with diabetes with Rozalina Sarkezians and Health Industry Hub. The discussion is particularly pertinent to this year's National Diabetes Week, as we explored the reasons why equitable and affordable access to insulin pumps and CGM can lead to better management of diabetes and its complications. Full podcast link: https://lnkd.in/gPyHBFNP Justine Cain Susan Davidson Taryn Black Diabetes Australia Australian Diabetes Educators Association Australian Diabetes Society

In reimagining healthcare, Adam Roach, VP & Head of Asia Pacific at BeiGene, delves into how the R&D and clinical trials ecosystem could radically transform over the next 10-15 years. "Governments are not set up to think holistically and strategically about R&D investment. Budgets and funding decisions tend to get made in silos," he states. A 14-year decline in national investment in science and biotech research has left Australia lagging behind the OECD average and less competitive internationally. "The question for us as a nation is do we want to be part of that next chapter in the Asia Pacific or not? We need to do more to keep pace," he emphasises. With #health and #medical #research accounting for 28% of Australian R&D expenditure, Adam says "We have earned a voice at the table. There is an opportunity for industry to bring resources and expertise to drive the policy discussion..." He adds, "What's really required is political courage and visionary leadership to think across governments and look holistically at the macro economic picture in Australia." Link to full vodcast: https://lnkd.in/gAC57-jc

Read more about how PenCS' new Diabetes QI Program in Practice Cloud is cutting hospitalisation for diabetes patients. Thank you for your coverage, Health Industry Hub. https://hubs.li/Q02GvWm40 #NationalDiabetesWeek #Diabetes #NewQIProgram #Health #Informatics #Technology #PracticeCloud

National Diabetes Week is here. We're proud to 'Unite in the Fight for Tech' and are committed to tackling #diabetes epidemic with the urgency it demands! Our ANZ Leader, Aviva Assouline, Senior Business Director for Diabetes joined Sof Andrikopoulos, CEO of Australian Diabetes Society (ADS) and Rozalina Sarkezians from Health Industry Hub to share insights on ways we can together as an industry and increase access to innovation for patients in Australia. Listen to the podcast now through the link below! #innovation

As National Diabetes Week kicks off, A/Professor Sof Andrikopoulos, CEO of Australian Diabetes Society (ADS), and Aviva Assouline, Senior Business Director Diabetes ANZ at Medtronic, are calling for the #diabetes epidemic to be tackled with the urgency it demands. The landmark diabetes inquiry report, hailed as a "Herculean effort by the committee", is a focal point of the discussion. Highlighting a crucial recommendation from the report, A/Professor Andrikopoulos, says "If we don't have health economic analysis to understand where the pain points are, how can we put plans together, put programs together, put activities together to address those areas of opportunity in diabetes?" With around two million Australians living with diabetes, this year's National Diabetes Week theme, 'Unite in the Fight for Tech,' is especially relevant. "Australia still lags behind other countries when we think about the pace in which new #innovation is launching and the access to that innovation," notes Viv. Full podcast link: https://lnkd.in/gPyHBFNP Medtronic Australia and New Zealand Diabetes Australia #nationalaiabetesweek #medtronic #endocrinologist  #endocronologist #health #healthcare

So proud of Gilead’s CAR T team, for their commitment to health equity for regional and rural communities in FNQ. My congratulations to all involved, and thank you to Jane Langford and Jessica Morison for their leadership.

🌟 Today marks Michael Roff's final day at the helm of the Australian Private Hospitals Association (APHA), leaving an indelible mark on the private health sector. In our recent interview, Michael reflected on his incredible journey, spanning two and a half decades, and shared his vision on how the sector can unlock greater value for patients. He expressed optimism for the new review of private hospitals announced by Federal Health Minister Mark Butler. "[The Department of Health] is obviously convinced by the data and they acted very quickly. They are undertaking their own data collection and analysis, and at the same time, looking at possible government policy responses," he stated. "In terms of unlocking value for consumers, the funding model needs to change to allow for private hospitals to provide more out of hospital community care under the auspices and by the staff of the hospitals, so that there is a continuum of care for private sector patients," he explained. "There are salient lessons from the banking Royal Commission. You don't want to get into the same sort of situation in private health, where a patient is being streamed into a particular care pathway, not because it's in their best clinical interests, but because it's in the best financial interest of their insurer," Michael stressed. Full podcast here: https://lnkd.in/gvqaiv6Z #health #healthcare #privatehealth #privatehospitals #hospitals #leadership #ceo Medical Technology Association of Australia (MTAA)